The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of 99mTc-trofolastat (MIP-1404) SPECT/CT to identify and localize prostate cancer in high-risk patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) compared to histopathology: An interim analysis.
Kevin Mark Slawin
Research Funding - Molecular Insight Pharmaceuticals
William J. Ellis
Research Funding - Progenics Pharmaceuticals
Peter Tenke
Research Funding - Progenics Pharmaceuticals
Steven Joniau
Research Funding - Progenics Pharmaceuticals
Boris Y. Alekseev
Research Funding - Progenics Pharmaceuticals
Istvan Buzogány
Research Funding - Progenics Pharmaceuticals
Sergey Mishugin
Research Funding - Progenics Pharmaceuticals
Eric A. Klein
Research Funding - Progenics Pharmaceuticals
R. Jeffrey Karnes
Research Funding - Progenics Pharmaceuticals
Douglas Scherr
Research Funding - Progenics Pharmaceuticals
Bertram E. Yuh
Research Funding - Progenics Pharmaceuticals
David Frasier Jarrard
Research Funding - Progenics Pharmaceuticals
Edouard John Trabulsi
Research Funding - Progenics Pharmaceuticals
Josef Stolz
Research Funding - Progenics Pharmaceuticals
John Babich
No relevant relationships to disclose
Hagop Youssoufian
Employment or Leadership Position - Progenics Pharmaceuticals
Nancy Stambler
Employment or Leadership Position - Progenics Pharmaceuticals
Thomas Armor
Employment or Leadership Position - Progenics Pharmaceuticals
Robert Joseph Israel
Employment or Leadership Position - Progenics Pharmaceuticals
Stock Ownership - Progenics Pharmaceuticals